In Vitro System | Donors | Methodology | Probe Substrate | Fold Range Activity | Reference |
---|---|---|---|---|---|
S-9 fraction | 6 | Metabolite formation | NMN | >40 | Rodrigues et al., 1994 |
Benzaldehyde | 3.6 | ||||
6-Methylpurine | 3.6 | ||||
Cytosol | 7 | Depletion | Benzaldehyde | 50 | Sugihara et al., 1997 |
Metabolite formation | NMN | 4.3 | |||
Cytosol | 6 | Metabolite formation | Methotrexate | 48 | Kitamura et al., 1999 |
Cytosol | 13 | Vmax/Km | DACA | 18 | Al-Salmy, 2001 |
Depletion | Benzaldehyde | 5 | |||
Cryopreserved hepatocytes | 5 | Metabolite formation | Vanillin | 5 | Sahi et al., 2008 |
Cytosol | 16 | Metabolite formation | NMN | 9.4 | Tayama et al., 2012 |
Cytosol | 20 | Depletion | Carbazeran | 90 | Fu et al., 2013 |
Zoniporide | 42 | ||||
Phthalazine | 17 |
DACA, N-[2-(dimethylamino)ethyl]acridone-4-carboxamide; NMN, N1-methylnicotinamide.